Study Stopped
low accrual
Episodic Future Thinking and Future Thinking Priming for Smoking Cessation
Promising Methods to Decrease Delay Discounting and Reduce Relapse to Smoking
2 other identifiers
interventional
26
1 country
1
Brief Summary
This trial studies the main and interactive effects of episodic future thinking and future thinking priming tasks on helping participants to quit smoking. Episodic future thinking and future thinking priming tasks may decrease delay discounting rates and reduce relapse to smoking and help participants quit smoking.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2020
CompletedFirst Submitted
Initial submission to the registry
February 28, 2020
CompletedFirst Posted
Study publicly available on registry
March 5, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 28, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 28, 2023
CompletedFebruary 8, 2024
February 1, 2024
4 years
February 28, 2020
February 6, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Change in Delay discounting rate
Assessed with the 5-Trial Adjusting Delay Discounting.
Baseline, and 4 and 12 weeks after quit date
Latency to relapse
Will be assessed with the Timeline Follow-Back procedure administered by telephone. Analyzed using generalized mixed models.
Baseline, assessed up to 12 weeks
Secondary Outcomes (7)
Latency to first relapse
up to 12 weeks
Number of days abstinent
Up to 12 weeks
7-day point prevalence abstinence rates
At 4 and 12 weeks after quit date
Attentional, motor, and non-planning impulsiveness
Up to 12 weeks
Behavioral inhibition and behavioral activation
Up to 12 weeks
- +2 more secondary outcomes
Study Arms (4)
Arm I (active EFT, active FTP)
EXPERIMENTALParticipants are provided with Forever Free relapse prevention booklets and receive a 2-week supply of nicotine patches, gum, or lozenges. Participants also receive 1 proactive coaching call within 24 hours of quit date. Beginning on the quit date, participants complete an active episodic future thinking or active future thinking priming task once per week for 12 weeks, alternating every week between tasks.
Arm II (active EFT, control FTP)
EXPERIMENTALParticipants are provided with Forever Free relapse prevention booklets and receive a 2-week supply of nicotine patches, gum, or lozenges. Participants also receive 1 proactive coaching call within 24 hours of quit date. Beginning on the quit date, participants complete an active episodic future thinking or control future thinking priming task once per week for 12 weeks, alternating every week between tasks.
Arm III (control EFT, active FTP)
EXPERIMENTALParticipants are provided with Forever Free relapse prevention booklets and receive a 2-week supply of nicotine patches, gum, or lozenges. Participants also receive 1 proactive coaching call within 24 hours of quit date. Beginning on the quit date, participants complete a control episodic future thinking or active future thinking priming task once per week for 12 weeks, alternating every week between tasks.
Arm IV (control EFT, control TFP)
ACTIVE COMPARATORParticipants are provided with Forever Free relapse prevention booklets and receive a 2-week supply of nicotine patches, gum, or lozenges. Participants also receive 1 proactive coaching call within 24 hours of quit date. Beginning on the quit date, participants complete a control episodic future thinking or control future thinking priming tasks once per week for 12 weeks, alternating every week between tasks.
Interventions
Complete active episodic thinking task
Provided with Forever Free relapse prevention booklet
Receive nicotine patches, gum, or lozenges
Receive coaching call
Eligibility Criteria
You may qualify if:
- Smoke \>= 8 cigarettes daily
- Planning to quit in the next 14 days
- No regular use of other tobacco products
- Access to the internet
- In possession of a smartphone with text messaging capabilities
- In possession of an email address accessible at least every other day
You may not qualify if:
- Unable or unwilling to provide consent
- Unable to provide data to the research team after the quit date
- Current use of bupropion or varenicline
- Drinking \>= 20 alcoholic drinks per week
- Use of drugs of abuse in the past 30 days
- Living in the same household as a participant already enrolled in this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Roswell Park Cancer Institute
Buffalo, New York, 14263, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christine Sheffer
Roswell Park Cancer Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 28, 2020
First Posted
March 5, 2020
Study Start
January 1, 2020
Primary Completion
December 28, 2023
Study Completion
December 28, 2023
Last Updated
February 8, 2024
Record last verified: 2024-02